Vanderbilt Eye Institute

January 7, 2016

Support for Eye Institute research a family affair

Sight is one of the most critical elements of a normal, happy life. When a child’s eyesight is threatened, his or her future stands to be permanently altered — and parents try to find the best treatment available.

By Jessica Pasley
December 3, 2015

Event celebrates scope of vision science at VUMC

Vision science at Vanderbilt has experienced tremendous growth in recent years.

By Jessica Pasley
June 25, 2015

Daniels receives research grant from Knights Templar Eye Foundation to study retinoblastoma treatment

Vanderbilt investigator Anthony Daniels has received a grant from the Knights Templar Eye Foundation to develop new, safe and effective treatments for retinoblastoma, the most common ocular cancer in children.

By Jessica Pasley
June 25, 2015

VEI receives grant from Research to Prevent Blindness for research and education

The Vanderbilt Eye Institute recently received a grant for $115,000 from Research to Prevent Blindness, placing the total award amount for unrestricted grants from the organization at $860,000.

By Jessica Pasley
March 23, 2015

Beware the eyes of March: Vanderbilt ophthalmologist offers tips for preventing and treating dry eyes during windy weather

By Jessica Pasley
February 12, 2015

VUMC’s Penn named president-elect of eye research society

John Penn, Ph.D., Phyllis G and William B. Snyder Endowed Professor of Ophthalmology and Visual Sciences, has been named president-elect of the International Society for Eye Research (ISER).

By Jessica Pasley
December 16, 2014

Retinal neuron survival in glaucoma

Understanding how the protein TRPV1 helps neurons survive after glaucoma-related stressors could lead to new therapeutic strategies for glaucoma and other neurodegenerative conditions.
By Leigh MacMillan
October 16, 2014

Project PAVE’s impact on children’s vision easy to see

It’s been 20 years since Project PAVE, a Tennessee program providing low-vision evaluations for children, was launched.
By Jessica Pasley
October 9, 2014

Novel therapy eases stress of retinoblastoma treatment

Conventional therapy for patients diagnosed with retinoblastoma, the most common ocular cancer in children, includes systemic chemotherapy, external beam radiation and/or surgical removal of the eye. Doctors at Vanderbilt University Medical Center are on track to radically change the way the disease is treated using an emerging therapeutic approach called intra-arterial chemotherapy, or IA chemo.
By Jessica Pasley
October 2, 2014

Regenerative visual neuroscience effort launched

Vanderbilt University has launched a regenerative visual neuroscience initiative to develop new ways of treating — and restoring sight to — people who have been blinded by glaucoma, macular degeneration, diabetic retinopathy and eye injuries.
By Bill Snyder
September 26, 2014

Biomarker for diabetic eye disease

A person’s mitochondrial gene “signature” could predict risk for diabetic retinopathy and guide early intervention strategies.
By Leigh MacMillan
August 19, 2014

Keeping an eye on blast trauma

Understanding the cellular and molecular responses of the eye to blast injury could guide new treatment development.
By Leigh MacMillan
August 14, 2014

Award highlights Wayman’s resident education efforts

Laura Wayman, M.D., associate professor of Ophthalmology and Visual Sciences, has been awarded the 2014 Straatsma Award for Excellence in Resident Education.
By Jessica Pasley
1 … 5 6 7 8 9 … 11